Armen Garo H, the executive chair and principal officer, has filed 54 Form 4 transactions across two companies. The pattern is one-sided. There are zero open-market sales, zero sales back to the issuer, and no gifts. The total open-market purchase value is $354,766.82, and the total acquired value, which includes compensation grants, is $726,393.85.
The recent activity concentrates on PTIX. Between July 30 and August 21, 2026, he made seven open-market purchases in that ticker. The values were $4,805.99 on July 30, $1,294 on August 5, $150.70 on August 6, $710.40 on August 11, $945 on August 19, $9,810.73 on August 20, and $13,000 on August 21. Those seven buys total roughly $30,716.82 and show an accelerating pace, with the two largest purchases coming on the final two dates.
The other ticker, AGEN, shows only code A transactions, which are grants or awards. Those are compensation, not purchases. The values are consistent, mostly between $14,700 and $16,300, and they appear on a biweekly schedule from January through August 2026. The August 10 grant had a value of $0. The buying bias is clear: every discretionary transaction in the filing history is a purchase, and the most recent direction is an increase in PTIX exposure.
AI-assisted summary